NCT03400969 is a NA clinical trial of Glycerol 17% in Xerostomia, sponsored by University of Bergen.

Who is sponsoring NCT03400969?

NCT03400969 is sponsored by University of Bergen.

What drugs are being tested in NCT03400969?

Interventions in NCT03400969: Glycerol 17%, Aequasyal (OGT), Salient (new product).

What condition does NCT03400969 study?

NCT03400969 studies Xerostomia.

Is NCT03400969 still recruiting?

NCT03400969 is currently status unknown. Last updated 29 October 2018.

Last reviewed 2018-10-29 · How we verify

NCT03400969

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Three Different Oral Moisturizers in Palliative Care Patients.

Status unknown NA Last updated 29 October 2018

What this trial tests

NA trial testing Glycerol 17% in Xerostomia in 30 participants. Status unknown.

Timeline

1 March 2018

Primary endpoint
15 December 2018

15 March 2019

Quick facts

Lead sponsor	University of Bergen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	supportive care
Enrollment	30
Start date	1 March 2018
Primary completion	15 December 2018
Estimated completion	15 March 2019
Sites	1 location across Norway

Drugs / interventions tested

Glycerol 17%
Aequasyal (OGT)
Salient (new product)

Conditions studied

Xerostomia — all drugs for Xerostomia →

Sponsor

University of Bergen

Who can join

Eligibility, any sex, with Xerostomia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the effectiveness of 3 different oral moisturizers; 17% watery solution of glycerol, OGT oral spray, Aequasyal, and a newly developed Product, Salient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Xerostomia

Currently open trials in the same condition.

NCT07394842 — Longitudinal Oral Health Changes After Head and Neck Radiotherapy · active not recruiting
NCT06465628 — Acupressure on Xerostomia in Head and Neck Cancer Patients · NA · recruiting
NCT06365047 — Dry Mouth Toothpaste Study - Comparing Two Toothpastes With Arginine · Phase 3 · active not recruiting
NCT06194123 — Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis · NA · active not recruiting
NCT06287294 — An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer · recruiting

Other University of Bergen trials

Trials by the same sponsor.

NCT07028450 — Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled St · NA · not yet recruiting
NCT04602572 — Obesity and Oral Diseases in Adult Patients · not yet recruiting
NCT07460817 — A Brief Intervention for PTSD - BWRT · NA · enrolling by invitation
NCT06960226 — Replication Study: Reducing Pain With Focused Music Listening · NA · completed
NCT07299669 — Effects of BEMER Electromagnetic Field Intervention on Sleep, Readiness to Play and Injuries in Elite Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03400969 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bergen
Last refreshed: 29 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03400969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing